
1. aten primaria. 2016 jun-jul;48(6):347-55. doi: 10.1016/j.aprim.2015.07.006. epub 
2015 oct 29.

[prevalence non-vaccinable high risk genotypes human papillomavirus 
early detection cervical cancer program cantabria].

[article spanish]

paz-zulueta m(1), fernández-feito a(2), amparán ruiz m(3), azofra olave a(3),
martín seco y(3), ojugas zabala s(3), otero garcía a(3), royano rasines c(3),
sarabia-lavín r(4), torres manrique b(4), santibáñez margüello m(5).

author information: 
(1)departamento de enfermería, universidad de cantabria, cantabria, españa.
electronic address: maria.paz@unican.es.
(2)área de enfermería, facultad de medicina ciencias de la salud, universidad
de oviedo, asturias, españa.
(3)gerencia de atención primaria, servicio cántabro de salud, cantabria, españa.
(4)departamento de enfermería, universidad de cantabria, cantabria, españa.
(5)departamento de ciencias médicas quirúrgicas, universidad de
cantabria-idival, cantabria, españa.

objective: estimate prevalence infection non-vaccinable high risk 
genotypes human papillomavirus (hpv).
design: cross-sectional study.
location: seven randomly selected health centres cantabria (northern spain).
participants: women evaluable vaginal smear (n=3,359) 2010
and 2011.
main measures: variables collected cytological diagnosis, pcr results,
and family planning method. vaginal smear results classified the
bethesda system. classification muñoz et al. used typing as
oncogenic risk hpv. proportions odds ratio (or) estimated with
corresponding confidence intervals 95% (95% ci).
results: prevalence hpv infection 2.71% (95% ci: 2.15 3.27). the
prevalence high oncogenic risk hpv genotypes 2.26%; (95% ci: 1.75 to
2.78). frequent genotype 16 (28.89%). half women
were positive one non-vaccinable high risk genotypes: 51 (18.89%) 
58 (13.33%) 68 (12.22%) 31 (11.11%). least two non-vaccinable high-risk
genotypes co-existed 23.33% women. younger women (≤30 years) twice 
risk hpv infection: 2.01 (95% ci: 1.02 3.96); twice as
likely use condoms compared hormonal contraceptives, 2.09 (95% ci: 1.64 
to 2.67).
conclusions: according high percentage non-vaccinable high oncogenic
risk hpv types, re-think prevention strategy the
population, may false sense protection.

copyright © 2015 elsevier españa, s.l.u. rights reserved.

doi: 10.1016/j.aprim.2015.07.006 
pmcid: pmc6877849
pmid: 26522783  [indexed medline]

